Small-cell lung cancer (SCLC) is an aggressive form of lung ... have emerged and are currently undergoing extensive research. Herein, we review the current treatment paradigm of immunotherapy in SCLC ...

The risk of developing liver cancer is increased in people who have cirrhosis, a disease in which healthy liver tissue is ...

Cancer a life-threatening disease can spread or metastasise from its original location to other parts of the body The lungs are a frequent site of metastasis An oncologist explains why ...

Researchers describe successful tumor removal through the use of immunotherapy and targeted radiation therapy (TARE), in a patient previously considered ineligible for the procedure.

Researchers have developed a computer model to help scientists identify tumor-fighting immune cells in patients with lung cancer treated with immune checkpoint inhibitors.

Heather Wakelee, MD, Stanford University, discusses the pros and cons of different durations of immunotherapy in non-small cell lung cancer (NSCLC) and the future outlook for patient-specific care.

Researchers reveal that gut microbiota influence the effectiveness of immune checkpoint inhibitors (ICIs) in cancer treatment ...

Newer treatments target pathways like Delta-like ligand 3, poly-ADP-ribose polymerase, and histone deacetylase to address ...

Oncolytic viruses (OVs) are viruses that infect and kill cancer cells while sparing healthy tissue, making them a promising therapeutic option in cancer ...

In a nutshell Researchers developed personalized cancer vaccines for nine high-risk kidney cancer patients, with all participants remaining cancer-free after nearly three years of follow-up – a ...

The assets being acquired include a Phase 2 lung cancer ... Priority Review Voucher, the Company is positioned to unlock the full potential of its market leading listeria-based immunotherapy ...